Histone Modification Research Compound Library | 组蛋白修饰化合物库 | MedChemExpress (MCE)
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
MedChemExpress (MCE) | 生产商 | 美国 | 现货 |
性能特点
A histone modification, a covalent post-translational modification (PTM) to histone proteins, in
A histone modification, a covalent post-translational modification (PTM) to histone proteins, includes methylation, phosphorylation, acetylation, ubiquitylation, and sumoylation, etc. In general, histone modifications are catalyzed by specific enzymes that act predominantly at the histone N-terminal tails involving amino acids such as lysine or arginine, as well as serine, threonine, tyrosine, etc. The PTMs made to histones can impact gene expression by altering chromatin structure or recruiting histone modifiers. Histone modifications act in diverse biological processes such as transcriptional activation/inactivation, chromosome packaging, and DNA damage/repair. Deregulation of histone modification contributes to many diseases, including cancer and autoimmune diseases. MCE owns a unique collection of 629 bioactive compounds targeting Epigenetic Reader Domain, HDAC, Histone Acetyltransferase, Histone Demethylase, Histone Methyltransferase, Sirtuin, etc. Histone Modification Research Compound Library is a useful tool for histone modification research and drug screening.更多产品详情查看:www.medchemexpress.cn/screening/Histone_Modification_Research_Compound_Library.html
Histone Modification Research Compound Library | 组蛋白修饰化合物库 | MedChemExpress (MCE)信息由MedChemExpress (MCE)为您提供,如您想了解更多关于Histone Modification Research Compound Library | 组蛋白修饰化合物库 | MedChemExpress (MCE)报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途